Health Condition 1: C570- Malignant neoplasm of fallopian tube Health Condition 2: C569- Malignant neoplasm of unspecifiedovary Health Condition 3: C577- Malignant neoplasm of other specified female genital organs
Conditions
Interventions
Control Intervention1: NIL: NIL
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: 1. High grade serous ovarian cancer (HGSOC) patients who had primary surgery which includes primary debulking surgery, interval debulking surgery and completion surgery at Tata Medical Center Kolkata 2. More than 18 years of age
Exclusion criteria
Exclusion criteria: 1. Epithelial ovarian cancers other than HGSOC and non-epithelial ovarian cancer patients. 2. Repeat cytoreductive surgery after disease recurrence. 3. Less than 18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome- To determine the association of germline BRCA mutations with rates of complete cytoreduction Timepoint: Final analysis of association between complete cytoreduction and BRCA mutation status will be done after complete recruitement of sample size that is in December 2025 | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the association of germline BRCA mutation with surgical complexity score. To estimate the progression free survival (PFS) & overall survival (OS) in the above cohort of patientsTimepoint: OS PFS analysed after 6 months of follow-up after completion of treatment association of BRCA mutation status with Surgical complexity score will be analysed after complete recruitement of sample size | — |
Countries
India
Contacts
Public ContactG. Raja
Tata Medical Center, Kolkata
Outcome results
None listed